Third time is the charm: Radius Health completes $48.4mm IPO after multiple tries

After two previous failed attempts to go public in the last two years, women’s health and osteoporosis drug developer Radius Health Inc. finally completed its IPO, netting $48.4mm through the sale of 6.5mm shares at $8. The company’s first attempt occurred in February 2012, but terms of 6.5mm shares for $8.50-10.50 were withdrawn later that year. It re-filed in February 2014, hoping to sell 5mm shares at $14-16, but that too was withdrawn just last month, to be followed less than three weeks later by the new filing, which closed shortly thereafter.